NinePoint Medical Appoints Eman Namati, Ph.D., to Chief Executive Officer

Neon Therapeutics Announces Closing of Initial Public Offering

Cedilla Therapeutics Expands Leadership Team with New Appointments to Direct Biology, Drug Discovery and Proteomics

GBT Announces Positive Top-line Data from Part A of the Phase 3 HOPE Study of Voxelotor in Sickle Cell Disease

Fulcrum Therapeutics Strengthens Board of Directors with Appointment of Kate Haviland